InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,929.04
(
2.53%
)
US TECH 100
20,202.80
(
2.61%
)
Dow Jones
43,729.93
(
3.57%
)
Brent Oil
74.97
(
-0.14%
)
Bitcoin
74,754.38
(
-1.18%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 89
Posts 18056
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: DewDiligence post# 4889

Tuesday, 09/04/2007 11:22:17 AM

Tuesday, September 04, 2007 11:22:17 AM

Post# of 19309
But doesn't fast-track generally imply priority review?

My understanding was that if a drug was fast-tracted it would generally recieve a priority review. Exceptions being if the NDA was for a different indication (than the basis of the fast track designation), or an improvement in SOC makes the drug a "me too".
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up